Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,174 across all filing types
Latest filing 2024-06-21 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Intimation regarding closure of Trading Window.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the closure of the trading window for designated persons due to insider trading regulations. It references SEBI regulations and the timing related to the announcement of financial results for the first quarter of FY 2024-25. The content is a regulatory announcement about trading restrictions, not a financial report, earnings release, or any detailed financial data. The document length is short (2025 characters) and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-06-21 English
Allotment of 43475 shares under ESOP.
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) regarding the allotment of shares under the company's Employee Stock Option Plan (ESOP). It specifies the number of shares allotted, the increase in issued and paid-up capital, and references compliance with SEBI Listing Regulations. The document is short (2021 characters) and serves as an announcement of a capital change due to share allotment under ESOP. It does not contain financial statements or detailed financial analysis, nor is it a report or presentation. Therefore, it fits the category of a Share Issue/Capital Change announcement.
2024-06-21 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) regarding the allotment of shares under the company's Employee Stock Option Plan (ESOP). It specifies the number of shares allotted, the increase in issued and paid-up capital, and references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30(2). The content is an announcement of a capital change due to share allotment under ESOP, not a full financial report or earnings release. The document length is short (2025 characters) and it is a direct disclosure of a capital event. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2024-06-21 English
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the loss of share certificate(s) for a shareholder and is addressed to stock exchanges. The content is a regulatory compliance communication rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion, nor is it an announcement of voting results or capital changes. It is a regulatory filing related to share certificate loss reporting, which fits best under the Regulatory Filings (RNS) category as a compliance certificate.
2024-06-19 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificate details received from a shareholder. It is addressed to stock exchanges and signed by the company secretary. The content is a regulatory compliance communication about share certificate loss, not a financial report, earnings release, or management information. It does not contain financial data or report results but is a regulatory filing to comply with stock exchange rules. The document length is short (2834 characters), and it is a formal certificate rather than a report or announcement of a report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-06-19 English
Lupin Appoints Abdelaziz Toumi as CEO of its API CDMO Subsidiary.
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new CEO for a subsidiary of Lupin Limited. It is addressed to stock exchanges and references compliance with SEBI Listing Regulations, specifically Regulation 30, which pertains to disclosure of material events. The content focuses on management appointment and company information rather than financial results or detailed reports. There are no financial statements, earnings data, or regulatory filings such as annual or quarterly reports. The document is a formal announcement of a management change, which fits the category of Board/Management Information (MANG). The document length is about 4930 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is MANG with high confidence.
2024-06-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.